Investor

Morningside Ventures

Last cheque observed Oct 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series ASeries CSeries BBusiness Development

Cheques on record
0%of best year0cheques in 12 months, 11 on record
Since the last cheque2574days00hrs00min00sec
Median round$20MRounds led2 of 11Sole investor3 roundsMostly inUnited States, 45%
Pitch Morningside Ventures

Morningside Ventures highlights

  1. 01

    11 rounds on record

  2. 02

    Mostly Series A and Series C: 70% of its rounds

  3. 03

    Sole investor in 3 rounds, median $15M

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
Business Development
Cold pitches
Not stated

The record

Every round we can evidence, newest first11 appearances

  1. 2019

    4 rounds

  2. Oct
    ImmunoMolecular TherapeuticsSeries A · US · FinSMEs$10MLed
  3. Sept
    Meissa VaccinesSeries A · US · FinSMEs$30MSole investor
  4. Sept
    InotremSeries B · FR · Benzinga$43MLed
  5. Sept
    MedAnnexGB · Heraldscotland$14MSole investor
  6. 2018

    1 round

  7. Jul
    UltrainSeries A · CN · AVCJ$20MWith 6 others
  8. 2015

    5 rounds

  9. Jul
    Xiaozhu.comSeries C · CN$60MWith 3 others
  10. Jun
    Advanced Cell DiagnosticsSeries C · US$22MWith 3 others
  11. Jun
    Kezar Life SciencesSeries A · US$23MWith 5 others
  12. Jun
    Luqa PharmaceuticalsSeries A · CN$15MSole investor
  13. May
    IwjwSeries D · CN$120MWith 1 other
  14. 2005

    1 round

  15. Nov
    BiddingForGoodVenture · US$10MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Recently backed

The latest companies Morningside Ventures put money into.

Meissa Vaccines$30M · Sept 2019Inotrem$43M · Sept 2019MedAnnex$14M · Sept 2019

Quick answers about Morningside Ventures

What does Morningside Ventures invest in?

Morningside Ventures invests most often at Series A and Series C (70% of the rounds on record), in sectors such as Business Development.

How active is Morningside Ventures?

11 investments on record, 0 of them in the last 12 months, and it led 2. The most recent was in Oct 2019.

What has Morningside Ventures invested in recently?

Its most recent investments on record: ImmunoMolecular Therapeutics (Series A, Oct 2019), Meissa Vaccines (Series A, Sept 2019) and Inotrem (Series B, Sept 2019).

How big are Morningside Ventures's cheques?

The median round it joins is $20M.

Does Morningside Ventures lead rounds?

Yes: it led 2 of its 11 investments on record (18%).

Where does Morningside Ventures invest?

Most of the companies it backs are in the United States (45%), China (36%) and France (9%).

Is Morningside Ventures investing now?

No investments in the last 12 months; the latest was in Oct 2019.

What kind of investor is Morningside Ventures?

Morningside Ventures is a VC firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it